Facility Head: Dr. Hafizur Rahman, MBBS
Dr Hafizur Rahman is a haematopathologist working as Head of Clinical Haematology and Cancer Biology Laboratory under icddr,b’s Laboratory Sciences and Services Division. The institute is a Bangladesh-based international health research institute that strives to solve key public health problems through high quality scientific research and innovation.
Dr Rahman graduated from Rangpur Medical College, University of Rajshahi, Bangladesh in 1996. After completing his internship training, he started his career at Dhaka Shishu Hospital, the largest paediatric hospital in Bangladesh in 1997 as a Medical Officer in the Department of Pathology. He then completed FCPS (Haematology) Part-I (basic) in January 2003 from Bangladesh College of Physicians and Surgeons and then undertook a four year fellowship training at the Haematology department at BSM Medical University. Dr Rahman joined icddr,b in 2006 as Senior Scientific Officer in Clinical Laboratories and he is currently serving as Head of Clinical Haematology and Cancer Biology Laboratory. His clinical interest is haemoglobinopathies and thalassemia as they have a very high prevalent in Bangladesh. He has also been associated with the thalassaemia community in Bangladesh for more than 20 years. Dr Rahman is also a member of “National Thalassemia Core Committee”. He has numerous publications in both national and internationally acclaimed journals including AJTMH, JHPN, BMC blood and BCPS journals.
The haematology laboratory provides routine haematology assays and specialty haematology testing for the Dhaka hospital, staff clinic and outreach. The laboratory strives to deliver high-quality, clinically impactful and cost-effective diagnostic services that are crucial to outstanding patient care. The lab is able to operate a wide range of basic and complex investigations including full blood count and blood film, ‘reflex’ analysis of blood smears and cytopathologic examination of body fluids; cytochemistry on blood and bone marrow; laboratory evaluation of coagulopathies and hypercoagulability; thalassaemia screening and identification of abnormal haemoglobins including specialty testing for hereditary spherocytosis and sickle cell disease;immunophenotyping of acute and chronic leukemia, lymphoma and multiple myeloma and detection of minimal residual diseases (MRD) by flow cytometry and molecular cytogenetics (RT-PCR) for diagnosis and prognostications of various leukaemias and lymphomas.
The laboratory has been a leader in auto-verification of routine hematology testing to speed both urgent care and protocol-driven clinical management, as well as cutting edge diagnostics for rapid identification of sepsis and hypercoagulable risk.